Feb 21, 2018
41 Views
0 0

Cognoa’s AI platform for autism diagnosis gets first FDA stamp

Written by

Cognoa has gained regulatory recognition for its machine learning software as a class II diagnostic medical device for autism — meaning the digital health startup is now positioned to submit an application for full FDA clearance. Read More

Cognoa has gained regulatory recognition for its machine learning software as a class II diagnostic medical device for autism — meaning the digital health startup is now positioned to submit an application for full FDA clearance. Read More

Article Categories:
Tech News

Leave a Reply

Your email address will not be published. Required fields are marked *